-
1
-
-
34548755151
-
The soluble epoxide hydrolase as a pharmaceutical target for hypertension
-
DOI 10.1097/FJC.0b013e3181506445, PII 0000534420070900000002
-
Chiamvimonvat N, Ho CM, Tsai HJ, et al. The soluble epoxide hydrolase as a pharmaceutical target for hypertension [J]. J Cardiovasc Pharmacol, 2007, 50: 225-237. (Pubitemid 47428969)
-
(2007)
Journal of Cardiovascular Pharmacology
, vol.50
, Issue.3
, pp. 225-237
-
-
Chiamvimonvat, N.1
Ho, C.-M.2
Tsai, H.-J.3
Hammock, B.D.4
-
2
-
-
64249112966
-
Mammalian epoxide hydrolases in xenobiotic metabolism and signalling
-
J
-
Decker M, Arand M, Cronin A. Mammalian epoxide hydrolases in xenobiotic metabolism and signalling [J]. Arch Toxicol, 2009, 83: 297-318.
-
(2009)
Arch Toxicol
, vol.83
, pp. 297-318
-
-
Decker, M.1
Arand, M.2
Cronin, A.3
-
3
-
-
0034534035
-
Epoxide hydrolases: Biochemistry and molecular biology
-
DOI 10.1016/S0009-2797(00)00197-6, PII S0009279700001976
-
Fretland AJ, Omiecinski CJ. Epoxide hydrolases: biochemistry and molecular biology [J]. Chem Biol Interact, 2000, 129: 41-59. (Pubitemid 32061053)
-
(2000)
Chemico-Biological Interactions
, vol.129
, Issue.1-2
, pp. 41-59
-
-
Fretland, A.J.1
Omiecinski, C.J.2
-
4
-
-
0242720683
-
Epoxyeicosatrienoic acids (EETs): Metabolism and biochemical function
-
DOI 10.1016/S0163-7827(03)00049-3
-
Spector AA, Fang X, Snyder GD, et al. Epoxyeicosatrienoic acids (EETs): metabolism and biochemical function [J]. Prog Lipid Res, 2004, 43: 55-90. (Pubitemid 37433867)
-
(2004)
Progress in Lipid Research
, vol.43
, Issue.1
, pp. 55-90
-
-
Spector, A.A.1
Fang, X.2
Snyder, G.D.3
Weintraub, N.L.4
-
5
-
-
33645846611
-
Emerging role of epoxyeicosatrienoic acids in coronary vascular function
-
J
-
Larsen BT, Gutterman DD, Hatoum OA. Emerging role of epoxyeicosatrienoic acids in coronary vascular function [J]. Eur J Clin Invest, 2006, 36: 293-300.
-
(2006)
Eur J Clin Invest
, vol.36
, pp. 293-300
-
-
Larsen, B.T.1
Gutterman, D.D.2
Hatoum, O.A.3
-
6
-
-
33845347545
-
Soluble epoxide hydrolase inhibition reveals novel biological functions of epoxyeicosatrienoic acids (EETs)
-
DOI 10.1016/j.prostaglandins.2006.05.004, PII S1098882306000578, Eicosanoid-Mediated Regulation of Vascular and Renal Function
-
Inceoglu B, Schmelzer KR, Morisseau C, et al. Soluble epoxide hydrolase inhibition reveals novel biological functions of epoxyeicosatrienoic acids (EETs) [J]. Prostaglandins Other Lipid Mediat, 2007, 82: 42-49. (Pubitemid 44880165)
-
(2007)
Prostaglandins and Other Lipid Mediators
, vol.82
, Issue.1-4
, pp. 42-49
-
-
Inceoglu, B.1
Schmelzer, K.R.2
Morisseau, C.3
Jinks, S.L.4
Hammock, B.D.5
-
7
-
-
15744382006
-
Soluble epoxide hydrolase is a main effector of angiotensin II-induced hypertension
-
DOI 10.1161/01.HYP.0000153792.29478.1d
-
Jung O, Brandes RP, Kim IH, et al. Soluble epoxide hydrolase is a main effector of angiotensin II-induced hypertension [J]. Hypertension, 2005, 45: 759-765. (Pubitemid 40418378)
-
(2005)
Hypertension
, vol.45
, Issue.4 SUPPL.
, pp. 759-765
-
-
Jung, O.1
Brandes, R.P.2
Kim, I.-H.3
Schweda, F.4
Schmidt, R.5
Hammock, B.D.6
Busse, R.7
Fleming, I.8
-
8
-
-
22244443733
-
Soluble epoxide hydrolase is a therapeutic target for acute inflammation
-
DOI 10.1073/pnas.0503279102
-
Schmelzer KR, Kubala L, Newman JW, et al. Soluble epoxide hydrolase is a therapeutic target for acute inflammation [J]. Proc Natl Acad Sci USA, 2005, 102: 9772-9777. (Pubitemid 40993644)
-
(2005)
Proceedings of the National Academy of Sciences of the United States of America
, vol.102
, Issue.28
, pp. 9772-9777
-
-
Schmelzer, K.R.1
Kubala, L.2
Newman, J.W.3
Kim, I.-H.4
Eiserich, J.P.5
Hammock, B.D.6
-
9
-
-
39049098184
-
Soluble epoxide hydrolase: A novel target for the treatment of hypertension
-
J
-
Fang X. Soluble epoxide hydrolase: a novel target for the treatment of hypertension [J]. Recent Pat Cardiovasc Drug Discov, 2006, 1: 67-72.
-
(2006)
Recent Pat Cardiovasc Drug Discov
, vol.1
, pp. 67-72
-
-
Fang, X.1
-
10
-
-
70349636047
-
Soluble epoxide hydrolase as a therapeutic target for cardiovascular diseases
-
J
-
Imig JD, Hammock BD. Soluble epoxide hydrolase as a therapeutic target for cardiovascular diseases [J]. Nat Rev Drug Discov, 2009, 8: 794-805.
-
(2009)
Nat Rev Drug Discov
, vol.8
, pp. 794-805
-
-
Imig, J.D.1
Hammock, B.D.2
-
11
-
-
67049119782
-
Soluble epoxide inhibition is protective against cerebral ischemia via vascular and neural protection
-
J
-
Simpkins AN, Rudic RD, Schreihofer DA, et al. Soluble epoxide inhibition is protective against cerebral ischemia via vascular and neural protection [J]. Am J Pathol, 2009, 174: 2086-2095.
-
(2009)
Am J Pathol
, vol.174
, pp. 2086-2095
-
-
Simpkins, A.N.1
Rudic, R.D.2
Schreihofer, D.A.3
-
12
-
-
22144444583
-
Fluorescent substrates for soluble epoxide hydrolase and application to inhibition studies
-
DOI 10.1016/j.ab.2005.03.041, PII S000326970500240X
-
Jones PD, Wolf NM, Morisseau C, et al. Fluorescent substrates for soluble epoxide hydrolase and application to inhibition studies [J]. Anal Biochem, 2005, 343: 66-75. (Pubitemid 40978610)
-
(2005)
Analytical Biochemistry
, vol.343
, Issue.1
, pp. 66-75
-
-
Jones, P.D.1
Wolf, N.M.2
Morisseau, C.3
Whetstone, P.4
Hock, B.5
Hammock, B.D.6
-
13
-
-
33745918021
-
Development of a high-throughput screen for soluble epoxide hydrolase inhibition
-
DOI 10.1016/j.ab.2006.04.045, PII S0003269706003265
-
Wolf NM, Morisseau C, Jones PD, et al. Development of a high-throughput screen for soluble epoxide hydrolase inhibition [J]. Anal Biochem, 2006, 355: 71-80. (Pubitemid 44041405)
-
(2006)
Analytical Biochemistry
, vol.355
, Issue.1
, pp. 71-80
-
-
Wolf, N.M.1
Morisseau, C.2
Jones, P.D.3
Hock, B.4
Hammock, B.D.5
-
14
-
-
0036570198
-
Structural refinement of inhibitors of urea-based soluble epoxide hydrolases
-
DOI 10.1016/S0006-2952(02)00952-8, PII S0006295202009528
-
Morisseau C, Goodrow MH, Newman JW, et al. Structural refinement of inhibitors of urea-based soluble epoxide hydrolases [J]. Biochem Pharmacol, 2002, 63: 1599-1608. (Pubitemid 34457999)
-
(2002)
Biochemical Pharmacology
, vol.63
, Issue.9
, pp. 1599-1608
-
-
Morisseau, C.1
Goodrow, M.H.2
Newman, J.W.3
Wheelock, C.E.4
Dowdy, D.L.5
Hammock, B.D.6
-
15
-
-
38849135612
-
High throughput screening for glutathione S-transferase inhibitors
-
J
-
Zhang DS, Zhang TT, Li SJ, et al. High throughput screening for glutathione S-transferase inhibitors [J]. Acta Pharm Sin, 2008, 43: 108-112.
-
(2008)
Acta Pharm Sin
, vol.43
, pp. 108-112
-
-
Zhang, D.S.1
Zhang, T.T.2
Li, S.J.3
-
16
-
-
34548070313
-
Orally bioavailable potent soluble epoxide hydrolase inhibitors
-
J
-
Hwang SH, Tsai HJ, Liu JY, et al. Orally bioavailable potent soluble epoxide hydrolase inhibitors [J]. J Med Chem, 2007, 50: 3825-3840.
-
(2007)
J Med Chem
, vol.50
, pp. 3825-3840
-
-
Hwang, S.H.1
Tsai, H.J.2
Liu, J.Y.3
-
17
-
-
0027219730
-
cDNA cloning and expression of a soluble epoxide hydrolase from human liver
-
J
-
Beetham JK, Tian T, Hammock BD. cDNA cloning and expression of a soluble epoxide hydrolase from human liver [J]. Arch Biochem Biophys, 1993, 305: 197-201.
-
(1993)
Arch Biochem Biophys
, vol.305
, pp. 197-201
-
-
Beetham, J.K.1
Tian, T.2
Hammock, B.D.3
-
18
-
-
0027171486
-
Molecular cloning and expression of murine liver soluble epoxide hydrolase
-
Grant DF, Storms DH, Hammock BD. Molecular cloning and expression of murine liver soluble epoxide hydrolase [J]. J Biol Chem, 1993, 268: 17628-17633. (Pubitemid 23237010)
-
(1993)
Journal of Biological Chemistry
, vol.268
, Issue.23
, pp. 17628-17633
-
-
Grant, D.F.1
Storms, D.H.2
Hammock, B.D.3
-
19
-
-
0028486021
-
Cloning and expression of soluble epoxide hydrolase from potato
-
Stapleton A, Beetham JK, Pinot F, et al. Cloning and expression of soluble epoxide hydrolase from potato [J]. Plant J, 1994, 6: 251-258. (Pubitemid 2120905)
-
(1994)
Plant Journal
, vol.6
, Issue.2
, pp. 251-258
-
-
Stapleton, A.1
Beetham, J.K.2
Pinot, F.3
Carbarino, J.E.4
Rockhold, D.R.5
Friedman, M.6
Hammock, B.D.7
Belknap, W.R.8
-
20
-
-
68749100411
-
Measurement of soluble epoxide hydrolase (sEH) activity
-
J
-
Morisseau C, Hammock BD. Measurement of soluble epoxide hydrolase (sEH) activity [J]. Curr Protoc Toxicol, 2007, 33 Suppl: 4.23.1-4.23.18.
-
(2007)
Curr Protoc Toxicol
, vol.33
, Issue.SUPPL.
-
-
Morisseau, C.1
Hammock, B.D.2
|